GE HealthCare Acquires SOFIE Biosciences for $945M to Expand PET Radiopharmaceutical Supply in US
GE HealthCare has acquired SOFIE Biosciences for $945 million to establish a 'Final Mile' footprint in the US for PET radiopharmaceutical supply. This acquisition aims to enhance GE HealthCare's capabilities in delivering PET radiopharmaceuticals, improving access and distribution within the United States.
BioSpectrum Asia·


